US Patent 7700593 Imidazo- and triazolo-pyridine compounds and methods of use thereof

Patent 7700593 was granted and assigned to Amgen on April, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Amgen

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7700593

Date of Patent

April 20, 2010

Patent Application Number

11973076

Date Filed

October 5, 2007

Patent Primary Examiner

‌

D. Margaret Seaman

Patent abstract

The present invention comprises a new class of compounds useful for the prophylaxis and treatment of protein kinase mediated diseases, including inflammation and related conditions. The compounds have a general Formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7700593 Imidazo- and triazolo-pyridine compounds and methods of use thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API